A Follow-up Study to Monitor Adult Height Among Spanish Children with Growth Hormone Deficiency Who Received Biosimilar Human Recombinant Growth Hormone (Omnitrope(®)) During a Phase III Clinical Trial

INTRODUCTION: An initial Phase III clinical trial has evaluated the efficacy and safety of biosimilar recombinant human growth hormone (rhGH; Omnitrope(®), Sandoz) in Spanish children with growth hormone deficiency (GHD). At the end of the study, those patients still growing were offered to remain o...

Descripción completa

Detalles Bibliográficos
Autores principales: Borrás Pérez, Victoria, López-Siguero, Juan Pedro, Martínez, Gabriela, Corripio, Raquel, Fernández, Juan Manuel, Labarta, Jose Ignacio, Ferrer, Marta, Cabrinety, Nuria, Prieto, Pablo, Ramón-Krauel, Marta, Bosch, Jordi, Espino, Rafael, Palla Garcia, Margarida, Rebollo, Francisco Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349959/
https://www.ncbi.nlm.nih.gov/pubmed/25667132
http://dx.doi.org/10.1007/s12325-015-0181-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349959/
https://www.ncbi.nlm.nih.gov/pubmed/25667132
http://dx.doi.org/10.1007/s12325-015-0181-9

Ejemplares similares